Atreca

Developer of antibody therapeutics for human anti-cancer immune responses

placeSan Carlos, California, United States calendar_todayFounded 2010 groups134 employees language atreca.com

Registered entities

Innovation

24 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 1,319 times.

YearFilings
20153
20161
20174
20185
20194
20205
20218
20229
202311
20247
20255
20261

Investor mix

16 investors on record; lead investors include Wellington, Aisling Capital, EcoR1, Tekla Capital Management; 1 has since exited.

Investor typeCountShare
Venture capital956%
Private equity16%
Other / undisclosed638%
Coming soon